Diabetes Symposium

The Indiana University Center for Diabetes and Metabolic Diseases aims to expand and integrate research in diabetes, obesity and metabolic diseases. Launched in 2014, the annual Diabetes Symposium is a key component in serving this mission.

At the annual event, nearly 200 attendees are immersed in an enriched learning environment that celebrates the latest in scientific discovery. The symposium presents unique opportunities to learn from nationally recognized experts, discuss recent scientific breakthroughs and forge relationships with potential collaborators.

Attend the symposium

The 2025 symposium is on Friday, Aug. 8 on the IU School of Medicine's campus in Indianapolis!

Registration is free and includes lunch if completed online by Friday, July 18. After the online registration deadline, only on-site registration on Aug. 8 will be available which does not include lunch.

Speaker presenting at the 2024 CDMD Symposium

Keynote Speakers

Each year, the symposium welcomes two renowned experts to present on the latest developments in their areas of expertise. This year's speakers are John Dennis, PhD, associate professor of health data science and Wellcome Trust Fellow at the University of Exeter Medical School, and Doris A. Stoffers, MD, PhD, Sylvan H. Eisman Professor of Medicine at the University of Pennsylvania.

Two symposium attendees looking at a research poster at the 2024 CDMD Symposium.

Poster Session

The annual poster session is an enriching opportunity to explore the latest updates from CDMD scientists. Students, trainees, staff and postdoctoral researchers in the CDMD community present developments from their laboratories on topics ranging from clinical research, diabetes education, islet biology, neuroscience, physiology, metabolism and more.

Resources and Additional Information

8:00 a.m.-12:00 p.m.	Poster set up	MS Atrium
8:00-8:50 a.m.	Registration / Breakfast	R3 Atrium
8:00-8:45 a.m.	Breakfast with Keynote Speakers and Students John Dennis, PhD University of Exeter Doris A. Stoffers, MD, PhD University of Pennsylvania	R3 207 & R3 303/305
8:50-9:00 a.m.	Welcome and Introduction Carmella Evans-Molina, MD, PhD Director, Center for Diabetes and Metabolic Diseases (CDMD) Lilly Professor of Pediatric Diabetes Indiana University School of Medicine, Indianapolis	R3 Auditorium
9:00-10:00 a.m.	Keynote Speaker John Dennis, PhD Associate Professor of Health Data Science Wellcome Trust Fellow University of Exeter, UK “Precision Treatment in Type 2 Diabetes: Progress and Prospects”	R3 Auditorium
10:00-10:30 a.m.	Plenary Talk 1 Priscilla A. Barnes, MPH, PhD, MCHES Associate Professor of Applied Health Science Founding Director, Center for Community-Engaged Implementation and Dissemination Research (CCEDIR) Indiana University School of Public Health, Bloomington “Beyond the Bench: Growing Research Impact from the Ground Up - Aligning Impact, Implementation, and Innovation with Community Priorities”	R3 Auditorium
10:30-11:00 a.m.	Break
11:00 a.m.-12:15 p.m.	Oral Abstract Presentations	R2 101/ R3 203 / R3 303-305 / R4 101
12:15-2:15 p.m.	Lunch	MS Atrium
12:45-2:15 p.m.	Poster Session	MS Atrium
2:30-3:00 p.m.	Plenary Talk 2 Viral Shah, MD Professor of Medicine Director of Diabetes Clinical Research, CDMD Indiana University School of Medicine, Indianapolis “Management of type 1 diabetes: from diabetes technologies to adjunctive therapies”	R3 Auditorium
3:00-3:30 p.m.	Pilot and Feasibility Program Awardees Gregory Henderson, PhD Assistant Professor of Nutrition Science Purdue University, West Lafayette “Plasma free fatty acid carrier proteins: regulators of lipid flux and glucoregulation” Kok Lim Kua, MD Assistant Professor of Pediatrics Indiana University School of Medicine, Indianapolis “Sex Differences in Offspring Beta Cell Response to Maternal Obesity: An Emerging Role for Hematopoietic Stem Cells”	R3 Auditorium
3:30-4:30 p.m.	Keynote Speaker Doris A. Stoffers, MD, PhD Sylvan H. Eisman Professor of Medicine Division of Endocrinology, Diabetes & Metabolism Associate Director, Penn Diabetes Research Center Director, Penn DRC Islet Cell Biology Core Director, Penn T32 in Diabetes, Endocrine and Metabolic Disease Perelman School of Medicine, University of Pennsylvania “Pancreatic beta cell adaptation to metabolic stress”	R3 Auditorium
4:30-4:50 p.m.	Oral Presentation Awards, Poster Awards and Closing Remarks Núria Morral, PhD Associate Professor of Medical and Molecular Genetics Enrichment Core Director Indiana University School of Medicine, Indianapolis	R3 Auditorium

The abstract submission deadline was June 18, 2024 (5:00 pm EST - close of business). Abstracts were submitted via the online registration portal. Abstracts are limited to 300 words, excluding title, authors, and affiliations. All abstracts should be submitted as a Word document. Abstracts that are larger than 300 words will not be accepted. For recommendations on how to write an abstract, please, scroll down.

General Formatting:

Please use Word to create and submit your abstract
Margins: 1” margins
Font: Arial in 11pt
Left justify all text
No tab stops at the beginning of the paragraph
No literature citations should be included in the abstract
Do not write text in all capital letters
Single line spacing
Structured or unstructured formats are acceptable

Abstracts are to be in one of the following categories:

Metabolism/Physiology
Clinical Research
Islet Biology/Pancreas
Immunology
Neuroscience
Other

If you submit an abstract, please, indicate whether you are willing to present in the Oral Abstract session. If you select ‘No,’ your abstract will be selected for poster presentation. A total of 20 abstracts will be selected for Oral Presentation.
If you have problems with your submission, please e-mail Shari R. Parker (shupchur@iu.edu). Should you need to make corrections on your submission, please do not submit a new abstract, and contact Shari R. Parker.

* * *Abstract Submission Deadline: Wednesday, June 18, 2025 (5:00 p.m. EST - close of business)

Poster Guidelines:

Mount your materials on your poster board at the time indicated below
Posters must be removed at the dismount time listed below
The poster must not exceed 4’ vertical and 8’ horizontal
Lettering should not be less than one and one-half inches
Illustrations should be similar to those you would use in making slides but more heavily drawn
One or two authors MUST be in attendance during the presentation times
Velcro tabs / pushpins will be provided

The purpose of the abstract is to provide a synopsis of your work in a clear (readable, well organized, avoiding jargon), concise (without excess wordiness or unnecessary information), and cohesive (nice flow between the parts) manner. These are guidelines that can help you write a compelling abstract:

Title
The title should clearly describe what your abstract is about, but also be interesting enough to encourage readers to want to learn more

Background and Objective

Should explain why your abstract is important or novel
Provide the context or explanation for doing the study, not the whole history but the current situation
1. What is already known about the subject?
2. What is not known, and hence what do you intend to examine?
Should state the aim of the study
1. What are you hoping to find out or what is your hypothesis?
Length: One to three sentences. If you have just started working on your project, it is appropriate to expand a bit more in this section

Methods

Should explain how you did your study
Specific population studied
1. Include sampling frames and response rates when appropriate
2. How many people/animals/samples were included in the research?
Quantitative or qualitative methods
1. Specific statistical analysis conducted
2. Measures and outcomes explored
Time frame duration of the study
Length: Three to eight sentences. If you have just started working on your project, it is appropriate to expand a bit more in this section and reduce the length of Results and Conclusions

Results

The results section should explain what you found
Describe your main findings with data
1. The intervention group was more likely than the control to use metformin - less good
2. The intervention group was more likely than the control to use metformin (p<0.01) - better
3. The intervention group was more likely than the control to use metformin (45% vs. 30%, p<0.01) - best
Concisely describe how your results pertain to your study aim or hypothesis
Remember to report nonsignificant differences too
Usually the longest section, three to eight sentences

Conclusions

This section should explain your main findings and why they are important
Describe the primary take-home message
Conclusions should be reasonable and supported by the findings
Include the Scientific/Clinical/Policy Impact of the research and Implications
Length: two to three sentences

Adapted from:

Andrade C. How to write a good abstract for a scientific paper or conference presentation. Indian J Psychiatry 2011;53:172-5.
IMPRS 2020 Abstract Submission, IU School of Medicine
CDC: How to write an abstract
Stroke 42(9):2605-10 (2011); doi: 10.1161/STROKEAHA.110.607101
Nature Medicine 28(4):798-808 (2022); doi: 10.1038/s41591-022-01718-1

Questions?

For additional information or questions about the symposium, contact program coordinator Shari Parker at shupchur@iu.edu.

Crowd of attendees listening to a presentation at the 2024 CDMD Sympsoium.

Diabetes Symposium

Attend the symposium

Keynote Speakers

Poster Session

Resources and Additional Information

Attend the symposium

Agenda

Abstract submissions and poster guidelines

Guidelines for writing an abstract

Questions?